Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Pfizer Stock Climbed Today

TheMotleyFool

0 0

Shares of Pfizer (NYSE: PFE) rose 2% on Tuesday after the drugmaker reported strong first-quarter growth.

Pfizer's revenue surged 77% year over year to $25.7 billion. Its adjusted net income soared 74% to $9.3 billion, or $1.62 per share. Both figures were well above Wall Street's consensus estimates for sales of $23.9 billion and adjusted earnings of $1.47 per share.

The gains were driven by staggering sales of Pfizer's COVID-19 vaccine and antiviral drugs. The pharmaceutical titan generated a whopping $13.2 billion in revenue from the Comirnaty vaccine and $1.5 billion from its Paxlovid antiviral treatment.

Source Fool.com

Like: 0

PFE

Share